TG Therapeutics Recaps Schedule of Upcoming Data Presentations at the XIX International Workshop on Chronic Lymphocytic Leukemia (iwCLL)

NEXT STORY
Olaparib Reduces Organ Damage in Sepsis
PREV STORY
Longeveron Partners with Kinesiometrics to Create and Implement Cutting-Edge Smart Phone App to Measure Physical Responses to Cell Therapy
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Rheumatology Community Urges CMS to Withdraw or Significantly Modify Part B Payment Demo

ATLANTA, May 5, 2016 (GLOBE NEWSWIRE) -- The American College of Rheumatology (ACR) today ...

author_avatar
NASDAQ Market News

Roche’s VENTANA PD-L1 (SP142) Assay approved as first companion diagnostic to identify triple-negative breast cancer patients eligible for treatment with Tecentriq in combination with Abraxane

author_avatar
NASDAQ Market News

OSE Immunotherapeutics Announces Licensing Deal for Neoepitope Combination Tedopi® in Korea with Chong Kun Dang Pharmaceutical Corporation

author_avatar
NASDAQ Market News